about
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinCannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammationThe thrifty lipids: endocannabinoids and the neural control of energy conservationInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationFunctional role of cannabinoid receptors in urinary bladder.Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.Rimonabant, gastrointestinal motility and obesity.Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.Novel insights which may translate into treatments for irritable bowel syndrome.Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum.Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.
P2860
Q24643876-288B46B1-C9E8-4921-A60D-033106C1A6DBQ24643922-39ED46E0-7F0C-4806-A9A8-F747C09BFB49Q26996134-75C18872-02AA-4C3D-8EFE-B62F93447009Q28258759-E2EAA9CC-ED81-46D2-B720-9ABAE6ABE513Q28568772-2BAE107C-1F96-41CD-8D88-66FB1B4D7A5FQ30357558-FEDCF31B-3A7D-48C9-987B-AA0C0DF3F440Q33884859-57EB0BE2-0063-4E15-8086-0EC884A4FD12Q34278963-62A120FC-87B7-4E43-BBC5-BCBBD6D27F70Q34534223-FC248AA9-C9AD-46D6-BC06-1E32D49EB6BEQ34547759-C8F6F412-9A40-42D1-B636-7424811B5844Q34571380-2C2B3EA4-2997-48EF-A688-BA3FB022998BQ34858094-16572DDA-4154-4A7D-BC39-34AAF4098282Q36341688-9778A561-A0FD-4AFA-ACA6-53DE71F23038Q37230665-43222F8E-C59D-48CF-8EE9-6A73181BB3D9Q37382150-DDDF6A1C-7236-448F-AF88-027E801AACD6Q37805184-ED5490AE-2760-472F-9E99-B354FBFBB83DQ38085530-5016057F-5973-4BFA-819C-CBD7EE6B14C6Q39417079-07FC7BFB-7659-417E-A7C3-DD4ED925C11DQ42150592-06AF6FFC-A726-4C47-957B-CB822F90630DQ42951297-3E7C99B6-698F-4956-9845-1C66F8B2152BQ55397242-D914F5CE-411A-4C86-8056-4A77EA4B861D
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cannabinoids and the digestive tract.
@ast
Cannabinoids and the digestive tract.
@en
type
label
Cannabinoids and the digestive tract.
@ast
Cannabinoids and the digestive tract.
@en
prefLabel
Cannabinoids and the digestive tract.
@ast
Cannabinoids and the digestive tract.
@en
P1476
Cannabinoids and the digestive tract.
@en
P2093
P304
P577
2005-01-01T00:00:00Z